Provided by Tiger Fintech (Singapore) Pte. Ltd.

Seres Therapeutics

9.40
+0.09000.97%
Post-market: 9.400.00000.00%19:02 EDT
Volume:56.25K
Turnover:528.35K
Market Cap:81.95M
PE:537.05
High:9.70
Open:9.33
Low:9.17
Close:9.31
Loading ...
Dec 07, 2020

Major Issues Report

8-K - Current report
Nov 25, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Nov 20, 2020

Major Issues Report

8-K - Current report
Nov 09, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 09, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Sep 10, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Sep 09, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Sep 08, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Aug 19, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 17, 2020

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Aug 14, 2020

Major Issues Report

8-K - Current report
Aug 13, 2020

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Aug 13, 2020

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Aug 10, 2020

Major Issues Report

8-K - Current report
Jul 28, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 22, 2020

Major Issues Report

8-K - Current report
May 07, 2020

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
May 07, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Mar 23, 2020

Major Issues Report

Current report, item 5.02
Mar 18, 2020

Major Issues Report

Current report, items 1.01, 8.01, and 9.01